B-type natriuretic peptide levels may be elevated in the critically injured trauma patient without congestive heart failure

Journal of Trauma - Injury, Infection and Critical Care

Volumn 63, Issue 4, 2007, Pages 747-750

  Stewart, David ^a   Waxman, Kenneth ^a,b   Brown, C Alan ^a   Schuster, Rob ^a   Schuster, Lynn ^a   Hvingelby, Eva Marie ^a   Kam, Kelly ^a   Becerra, Salvador ^a  

^a SANTA BARBARA COTTAGE HOSPITAL   (United States)

^b Department of Surgery ^*  (United States)

Author keywords

B type natriuretic peptide; Echocardiography; GCS; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; FEMALE; FISHER EXACT TEST; GLASGOW COMA SCALE; HEAD INJURY; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MALE; MEASUREMENT; PRIORITY JOURNAL; SYSTOLIC DYSFUNCTION;

ADULT; CRITICAL ILLNESS; FEMALE; HEART FAILURE; HUMANS; INJURY SEVERITY SCORE; INTRACRANIAL HEMORRHAGE, TRAUMATIC; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; WOUNDS AND INJURIES;

EID: 37348999887     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000240458.46050.38     Document Type: Article

References (11)

1. Packer M, Cohn JN, Abraham WT, et al. Consensus recommendations for the management of chronic heart failure. Am J Cardiol. 1999;83(Suppl):1A-38A.
2. Bales AC, Sorrentino MJ. Causes of congestive heart failure: prompt diagnosis may affect prognosis. Postgrad Med. 1997;101:44-49, 54-56.
3. Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest. 1995;96:1280-1287.
4. Maeda K, Tsutamota, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825-832.
5. Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med. 2001;111:274-279.
6. Cheng VL, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 201;37:386-391.
7. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J. 2001;141:367-374.
8. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med. 2002;39:131-138.
9. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161-167.
10. Rakowski H, Appleton CP, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography. From the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr. 1996;9:736-760.
11. Kia M, Cooley A, Rimmer G, et al. The efficacy of B-type natriuretic peptide for early identification of blood loss in traumatic injury. Am J Surg. 2006;191:353-357.